ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pan-cancer Genetic Testing Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-22V18893
Home | Market Reports | Science| Biological Sciences
Global Pan cancer Genetic Testing Market Research Report 2025
BUY CHAPTERS

Global Pan-cancer Genetic Testing Market Research Report 2025

Code: QYRE-Auto-22V18893
Report
February 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Eurofins Scientific
Natera
Shenzhen BGI
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Genotypic Technology
Dna Link
Burning Rock Medicine
Beijing Novogene Technology
Science and Gene

Pan-cancer Genetic Testing Market Size

The global market for Pan-cancer Genetic Testing was valued at US$ 4969 million in the year 2024 and is projected to reach a revised size of US$ 7163 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Pan-cancer Genetic Testing Market

Pan-cancer Genetic Testing Market

Pan-cancer genetic testing is a technique used to detect mutations or alterations in genes associated with various types of cancer. By analyzing an individual’s genomic information, it can identify genetic variations linked to different cancers (such as lung, breast, colorectal cancers, etc.), providing critical insights for early diagnosis, personalized treatment, and prognostic assessment.
North American market for Pan-cancer Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pan-cancer Genetic Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pan-cancer Genetic Testing in Hospitals and Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pan-cancer Genetic Testing include Illumina, Eurofins Scientific, Natera, Shenzhen BGI, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pan-cancer Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pan-cancer Genetic Testing.
The Pan-cancer Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pan-cancer Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pan-cancer Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pan-cancer Genetic Testing Market Report

Report Metric Details
Report Name Pan-cancer Genetic Testing Market
Accounted market size in year US$ 4969 million
Forecasted market size in 2031 US$ 7163 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Biopharmaceutical Companies
  • Academic Research Institutions
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Eurofins Scientific, Natera, Shenzhen BGI, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Beijing Novogene Technology, Genotypic Technology, Dna Link, Burning Rock Medicine, Science and Gene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pan-cancer Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pan-cancer Genetic Testing Market growing?

Ans: The Pan-cancer Genetic Testing Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Pan-cancer Genetic Testing Market size in 2031?

Ans: The Pan-cancer Genetic Testing Market size in 2031 will be US$ 7163 million.

Who are the main players in the Pan-cancer Genetic Testing Market report?

Ans: The main players in the Pan-cancer Genetic Testing Market are Illumina, Eurofins Scientific, Natera, Shenzhen BGI, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Beijing Novogene Technology, Genotypic Technology, Dna Link, Burning Rock Medicine, Science and Gene

What are the Application segmentation covered in the Pan-cancer Genetic Testing Market report?

Ans: The Applications covered in the Pan-cancer Genetic Testing Market report are Hospitals and Clinics, Biopharmaceutical Companies, Academic Research Institutions, Other

What are the Type segmentation covered in the Pan-cancer Genetic Testing Market report?

Ans: The Types covered in the Pan-cancer Genetic Testing Market report are NGS Testing, Other Testing

Recommended Reports

Cancer Diagnostics

Genetic Testing

Gene Mutation Detection

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pan-cancer Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NGS Testing
1.2.3 Other Testing
1.3 Market by Application
1.3.1 Global Pan-cancer Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Biopharmaceutical Companies
1.3.4 Academic Research Institutions
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pan-cancer Genetic Testing Market Perspective (2020-2031)
2.2 Global Pan-cancer Genetic Testing Growth Trends by Region
2.2.1 Global Pan-cancer Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pan-cancer Genetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Pan-cancer Genetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Pan-cancer Genetic Testing Market Dynamics
2.3.1 Pan-cancer Genetic Testing Industry Trends
2.3.2 Pan-cancer Genetic Testing Market Drivers
2.3.3 Pan-cancer Genetic Testing Market Challenges
2.3.4 Pan-cancer Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pan-cancer Genetic Testing Players by Revenue
3.1.1 Global Top Pan-cancer Genetic Testing Players by Revenue (2020-2025)
3.1.2 Global Pan-cancer Genetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Top Pan-cancer Genetic Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pan-cancer Genetic Testing Revenue
3.4 Global Pan-cancer Genetic Testing Market Concentration Ratio
3.4.1 Global Pan-cancer Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pan-cancer Genetic Testing Revenue in 2024
3.5 Global Key Players of Pan-cancer Genetic Testing Head office and Area Served
3.6 Global Key Players of Pan-cancer Genetic Testing, Product and Application
3.7 Global Key Players of Pan-cancer Genetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pan-cancer Genetic Testing Breakdown Data by Type
4.1 Global Pan-cancer Genetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Pan-cancer Genetic Testing Forecasted Market Size by Type (2026-2031)
5 Pan-cancer Genetic Testing Breakdown Data by Application
5.1 Global Pan-cancer Genetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Pan-cancer Genetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pan-cancer Genetic Testing Market Size (2020-2031)
6.2 North America Pan-cancer Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pan-cancer Genetic Testing Market Size by Country (2020-2025)
6.4 North America Pan-cancer Genetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pan-cancer Genetic Testing Market Size (2020-2031)
7.2 Europe Pan-cancer Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pan-cancer Genetic Testing Market Size by Country (2020-2025)
7.4 Europe Pan-cancer Genetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pan-cancer Genetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Pan-cancer Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pan-cancer Genetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Pan-cancer Genetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pan-cancer Genetic Testing Market Size (2020-2031)
9.2 Latin America Pan-cancer Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pan-cancer Genetic Testing Market Size by Country (2020-2025)
9.4 Latin America Pan-cancer Genetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pan-cancer Genetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Pan-cancer Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pan-cancer Genetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Pan-cancer Genetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Pan-cancer Genetic Testing Introduction
11.1.4 Illumina Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Pan-cancer Genetic Testing Introduction
11.2.4 Eurofins Scientific Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Pan-cancer Genetic Testing Introduction
11.3.4 Natera Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.3.5 Natera Recent Development
11.4 Shenzhen BGI
11.4.1 Shenzhen BGI Company Details
11.4.2 Shenzhen BGI Business Overview
11.4.3 Shenzhen BGI Pan-cancer Genetic Testing Introduction
11.4.4 Shenzhen BGI Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.4.5 Shenzhen BGI Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Pan-cancer Genetic Testing Introduction
11.5.4 Roche Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Pan-cancer Genetic Testing Introduction
11.6.4 LabCorp Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Pan-cancer Genetic Testing Introduction
11.7.4 Berry Genomics Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.7.5 Berry Genomics Recent Development
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Details
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences Pan-cancer Genetic Testing Introduction
11.8.4 Brooks Life Sciences Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.8.5 Brooks Life Sciences Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Pan-cancer Genetic Testing Introduction
11.9.4 Macrogen Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.9.5 Macrogen Recent Development
11.10 Personalis
11.10.1 Personalis Company Details
11.10.2 Personalis Business Overview
11.10.3 Personalis Pan-cancer Genetic Testing Introduction
11.10.4 Personalis Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.10.5 Personalis Recent Development
11.11 Beijing Novogene Technology
11.11.1 Beijing Novogene Technology Company Details
11.11.2 Beijing Novogene Technology Business Overview
11.11.3 Beijing Novogene Technology Pan-cancer Genetic Testing Introduction
11.11.4 Beijing Novogene Technology Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.11.5 Beijing Novogene Technology Recent Development
11.12 Genotypic Technology
11.12.1 Genotypic Technology Company Details
11.12.2 Genotypic Technology Business Overview
11.12.3 Genotypic Technology Pan-cancer Genetic Testing Introduction
11.12.4 Genotypic Technology Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.12.5 Genotypic Technology Recent Development
11.13 Dna Link
11.13.1 Dna Link Company Details
11.13.2 Dna Link Business Overview
11.13.3 Dna Link Pan-cancer Genetic Testing Introduction
11.13.4 Dna Link Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.13.5 Dna Link Recent Development
11.14 Burning Rock Medicine
11.14.1 Burning Rock Medicine Company Details
11.14.2 Burning Rock Medicine Business Overview
11.14.3 Burning Rock Medicine Pan-cancer Genetic Testing Introduction
11.14.4 Burning Rock Medicine Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.14.5 Burning Rock Medicine Recent Development
11.15 Science and Gene
11.15.1 Science and Gene Company Details
11.15.2 Science and Gene Business Overview
11.15.3 Science and Gene Pan-cancer Genetic Testing Introduction
11.15.4 Science and Gene Revenue in Pan-cancer Genetic Testing Business (2020-2025)
11.15.5 Science and Gene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Illumina Inc
Eurofins Scientific
Natera
Shenzhen BGI
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Genotypic Technology
Dna Link
Burning Rock Medicine
Beijing Novogene Technology
Science and Gene
List of Tables
 Table 1. Global Pan-cancer Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of NGS Testing
 Table 3. Key Players of Other Testing
 Table 4. Global Pan-cancer Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pan-cancer Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pan-cancer Genetic Testing Market Share by Region (2020-2025)
 Table 8. Global Pan-cancer Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pan-cancer Genetic Testing Market Share by Region (2026-2031)
 Table 10. Pan-cancer Genetic Testing Market Trends
 Table 11. Pan-cancer Genetic Testing Market Drivers
 Table 12. Pan-cancer Genetic Testing Market Challenges
 Table 13. Pan-cancer Genetic Testing Market Restraints
 Table 14. Global Pan-cancer Genetic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pan-cancer Genetic Testing Market Share by Players (2020-2025)
 Table 16. Global Top Pan-cancer Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pan-cancer Genetic Testing as of 2024)
 Table 17. Ranking of Global Top Pan-cancer Genetic Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pan-cancer Genetic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pan-cancer Genetic Testing, Headquarters and Area Served
 Table 20. Global Key Players of Pan-cancer Genetic Testing, Product and Application
 Table 21. Global Key Players of Pan-cancer Genetic Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pan-cancer Genetic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pan-cancer Genetic Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Pan-cancer Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pan-cancer Genetic Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Pan-cancer Genetic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pan-cancer Genetic Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Pan-cancer Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pan-cancer Genetic Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Pan-cancer Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pan-cancer Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pan-cancer Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pan-cancer Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pan-cancer Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pan-cancer Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pan-cancer Genetic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pan-cancer Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pan-cancer Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pan-cancer Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pan-cancer Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pan-cancer Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Illumina Company Details
 Table 47. Illumina Business Overview
 Table 48. Illumina Pan-cancer Genetic Testing Product
 Table 49. Illumina Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 50. Illumina Recent Development
 Table 51. Eurofins Scientific Company Details
 Table 52. Eurofins Scientific Business Overview
 Table 53. Eurofins Scientific Pan-cancer Genetic Testing Product
 Table 54. Eurofins Scientific Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 55. Eurofins Scientific Recent Development
 Table 56. Natera Company Details
 Table 57. Natera Business Overview
 Table 58. Natera Pan-cancer Genetic Testing Product
 Table 59. Natera Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 60. Natera Recent Development
 Table 61. Shenzhen BGI Company Details
 Table 62. Shenzhen BGI Business Overview
 Table 63. Shenzhen BGI Pan-cancer Genetic Testing Product
 Table 64. Shenzhen BGI Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 65. Shenzhen BGI Recent Development
 Table 66. Roche Company Details
 Table 67. Roche Business Overview
 Table 68. Roche Pan-cancer Genetic Testing Product
 Table 69. Roche Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 70. Roche Recent Development
 Table 71. LabCorp Company Details
 Table 72. LabCorp Business Overview
 Table 73. LabCorp Pan-cancer Genetic Testing Product
 Table 74. LabCorp Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 75. LabCorp Recent Development
 Table 76. Berry Genomics Company Details
 Table 77. Berry Genomics Business Overview
 Table 78. Berry Genomics Pan-cancer Genetic Testing Product
 Table 79. Berry Genomics Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 80. Berry Genomics Recent Development
 Table 81. Brooks Life Sciences Company Details
 Table 82. Brooks Life Sciences Business Overview
 Table 83. Brooks Life Sciences Pan-cancer Genetic Testing Product
 Table 84. Brooks Life Sciences Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 85. Brooks Life Sciences Recent Development
 Table 86. Macrogen Company Details
 Table 87. Macrogen Business Overview
 Table 88. Macrogen Pan-cancer Genetic Testing Product
 Table 89. Macrogen Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 90. Macrogen Recent Development
 Table 91. Personalis Company Details
 Table 92. Personalis Business Overview
 Table 93. Personalis Pan-cancer Genetic Testing Product
 Table 94. Personalis Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 95. Personalis Recent Development
 Table 96. Beijing Novogene Technology Company Details
 Table 97. Beijing Novogene Technology Business Overview
 Table 98. Beijing Novogene Technology Pan-cancer Genetic Testing Product
 Table 99. Beijing Novogene Technology Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 100. Beijing Novogene Technology Recent Development
 Table 101. Genotypic Technology Company Details
 Table 102. Genotypic Technology Business Overview
 Table 103. Genotypic Technology Pan-cancer Genetic Testing Product
 Table 104. Genotypic Technology Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 105. Genotypic Technology Recent Development
 Table 106. Dna Link Company Details
 Table 107. Dna Link Business Overview
 Table 108. Dna Link Pan-cancer Genetic Testing Product
 Table 109. Dna Link Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 110. Dna Link Recent Development
 Table 111. Burning Rock Medicine Company Details
 Table 112. Burning Rock Medicine Business Overview
 Table 113. Burning Rock Medicine Pan-cancer Genetic Testing Product
 Table 114. Burning Rock Medicine Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 115. Burning Rock Medicine Recent Development
 Table 116. Science and Gene Company Details
 Table 117. Science and Gene Business Overview
 Table 118. Science and Gene Pan-cancer Genetic Testing Product
 Table 119. Science and Gene Revenue in Pan-cancer Genetic Testing Business (2020-2025) & (US$ Million)
 Table 120. Science and Gene Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Pan-cancer Genetic Testing Picture
 Figure 2. Global Pan-cancer Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pan-cancer Genetic Testing Market Share by Type: 2024 VS 2031
 Figure 4. NGS Testing Features
 Figure 5. Other Testing Features
 Figure 6. Global Pan-cancer Genetic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pan-cancer Genetic Testing Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals and Clinics Case Studies
 Figure 9. Biopharmaceutical Companies Case Studies
 Figure 10. Academic Research Institutions Case Studies
 Figure 11. Other Case Studies
 Figure 12. Pan-cancer Genetic Testing Report Years Considered
 Figure 13. Global Pan-cancer Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pan-cancer Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pan-cancer Genetic Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Pan-cancer Genetic Testing Market Share by Players in 2024
 Figure 17. Global Pan-cancer Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Pan-cancer Genetic Testing Revenue in 2024
 Figure 19. North America Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pan-cancer Genetic Testing Market Share by Country (2020-2031)
 Figure 21. United States Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pan-cancer Genetic Testing Market Share by Country (2020-2031)
 Figure 25. Germany Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pan-cancer Genetic Testing Market Share by Region (2020-2031)
 Figure 33. China Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pan-cancer Genetic Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pan-cancer Genetic Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pan-cancer Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Illumina Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 49. Eurofins Scientific Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 50. Natera Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 51. Shenzhen BGI Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 52. Roche Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 53. LabCorp Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 54. Berry Genomics Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 55. Brooks Life Sciences Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 56. Macrogen Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 57. Personalis Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 58. Beijing Novogene Technology Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 59. Genotypic Technology Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 60. Dna Link Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 61. Burning Rock Medicine Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 62. Science and Gene Revenue Growth Rate in Pan-cancer Genetic Testing Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Multi Cancer Detection Blood Test Market Research Report 2024
Global Molecular Diagnostics Cancer Market Insights Forecast to 2030
Global DNA Genomic Testing Market Research Report 2024
Global Customized Genetic Testing Market Research Report 2025
Global DNA Genetic Testing Kit Market Research Report 2024
Global Genomic Testing in Cancer Market Research Report 2024
Global Lung Cancer Genomic Testing Market Research Report 2024
Global Somatic Genetic Testing Market Research Report 2024
Global Cancer Genomic Testing Market Research Report 2024
Genetic Testing for Cancer Risk Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Panel Market Research Report 2024
Global Tumor NGS Genetic Testing Market Research Report 2024
Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024
Global DNA Bowel Cancer Screening Kits Market Research Report 2024
Global Gene Panel Test Kit Market Insights Forecast to 2030
Global Precision Cancer Tests Market Research Report 2024
Global Prenatal Genetic Screening Test Market Research Report 2024
Global Carrier Screening Tests Market Research Report 2024
Global SNP Microarray Testing and Analysis Market Research Report 2025
Global Inherited Cancer Genome Testing Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions